“The general public has started trading fixed-income securities for stocks,” Jim Cramer said on Monday’s  “Stop Trading!” segment. He pointed to Merck & Co., Inc. (NYSE:MRK) and Boeing Company (NYSE:BA), which are both flying despite little good news at either company. Cramer explained that this type of action usually happens when the general public starts to put new money into the market, usually the S&P 500. He said he’s very pro-Boeing and the dividend will pay you as you wait. Cramer mentioned he also likes Intel Corp. (NASDAQ:INTC) after the company announced it will boost its dividend.  “You can’t have a Dell Inc. (NASDAQ:DELL) upgrade without thinking good things about Intel,” he said. “You can’t have Microsoft (NASDAQ:MSFT) do well without Intel doing well.” Cramer told viewers that Intel’s dividend increase was a message from the company to Wall Street that says, “Listen, You don’t understand how good things are.” Lastly, Cramer recommended Bristol-Myers Squibb Co. (NYSE:BMY), a stock he holds in his charitable trust. He said Exelixis Inc. (NASDAQ:EXEL), Allos Therapeutics Inc. (ALTH) and ImmunoGen (NASDAQ:IMGN) are all potential targets for Bristol to extend the company’s cancer franchise. He called CEO James Cornelius “money in the bank” and “fabulous.”   Get the scoop on tomorrow’s hottest trade ideas – TODAY! BeaconEquity.com PREMIER PICKS have an amazing track record. Join this select group and ride the profit wave!